NALOXONE HYDROCHLORIDE — all Canadian products
19 DINs
15 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NALOXONE HYDROCHLORIDE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02555441 | KLOXXADO | HIKMA CANADA LIMITED | Spray (Metered-Dose) | Nasal | NALOXONE HYDROCHLORIDE 8 MG | Approved | |
| 02148706 | NALOXONE HCL INJECTION - 0.4MG/ML USP | SANDOZ CANADA INCORPORATED | Liquid | Intravenous; Subcutaneous; Intramuscular | NALOXONE HYDROCHLORIDE 0.4 MG | Marketed | |
| 02148714 | NALOXONE HCL INJECTION - 1MG/ML USP | SANDOZ CANADA INCORPORATED | Liquid | Intravenous; Subcutaneous; Intramuscular | NALOXONE HYDROCHLORIDE 1 MG | Marketed | |
| 02548194 | NALOXONE HYDROCHLORIDE INJECTION USP | STERINOVA INC. | Solution | Intramuscular; Subcutaneous | NALOXONE HYDROCHLORIDE 0.4 MG | Marketed | |
| 02518066 | NALOXONE HYDROCHLORIDE INJECTION, USP | BAXTER CORPORATION | Solution | Intramuscular; Subcutaneous; Intravenous | NALOXONE HYDROCHLORIDE 0.4 MG | Approved | |
| 02515261 | NALOXONE HYDROCHLORIDE INJECTION, USP | AURO PHARMA INC | Solution | Intramuscular; Intravenous; Subcutaneous | NALOXONE HYDROCHLORIDE 0.4 MG | Approved | |
| 02515288 | NALOXONE HYDROCHLORIDE INJECTION, USP | AURO PHARMA INC | Solution | Intravenous; Subcutaneous; Intramuscular | NALOXONE HYDROCHLORIDE 4 MG | Approved | |
| 02534975 | NALOXONE HYDROCHLORIDE INJECTION, USP | EUGIA PHARMA INC. | Solution | Intramuscular; Intravenous; Subcutaneous | NALOXONE HYDROCHLORIDE 4 MG | Marketed | |
| 02534967 | NALOXONE HYDROCHLORIDE INJECTION, USP | EUGIA PHARMA INC. | Solution | Intravenous; Subcutaneous; Intramuscular | NALOXONE HYDROCHLORIDE 0.4 MG | Approved | |
| 02518074 | NALOXONE HYDROCHLORIDE INJECTION, USP | BAXTER CORPORATION | Solution | Subcutaneous; Intravenous; Intramuscular | NALOXONE HYDROCHLORIDE 0.4 MG | Approved | |
| 02458578 | NALOXONE INJECTABLE | HIKMA CANADA LIMITED | Solution | Intravenous; Intramuscular; Subcutaneous | NALOXONE HYDROCHLORIDE 0.4 MG | Marketed | |
| 02458187 | NARCAN NASAL SPRAY | EMERGENT OPERATIONS IRELAND LIMITED | Spray (Metered-Dose) | Nasal | NALOXONE HYDROCHLORIDE 4 MG | Marketed | |
| 02458179 | NARCAN NASAL SPRAY | EMERGENT OPERATIONS IRELAND LIMITED | Spray (Metered-Dose) | Nasal | NALOXONE HYDROCHLORIDE 2 MG | Approved | |
| 02453258 | S.O.S. NALOXONE HYDROCHLORIDE INJECTION | SANDOZ CANADA INCORPORATED | Solution | Intramuscular; Subcutaneous; Intravenous | NALOXONE HYDROCHLORIDE 0.4 MG | Marketed | |
| 02511568 | TEVA-NALOXONE NASAL SPRAY | TEVA CANADA LIMITED | Spray (Metered-Dose) | Nasal | NALOXONE HYDROCHLORIDE 4 MG | Marketed | |
| 01913948 | NARCAN INJECTION 0.02MG/ML | BRISTOL-MYERS SQUIBB CANADA | Liquid | Subcutaneous; Intramuscular; Intravenous | NALOXONE HYDROCHLORIDE 0.02 MG | Cancelled Post Market | |
| 01913956 | NARCAN INJECTION 0.4MG/ML | BRISTOL-MYERS SQUIBB CANADA | Solution | Subcutaneous; Intravenous; Intramuscular | NALOXONE HYDROCHLORIDE 0.4 MG | Cancelled Post Market | |
| 01913964 | NARCAN INJECTION 1MG/ML | BRISTOL-MYERS SQUIBB CANADA | Liquid | Subcutaneous; Intravenous; Intramuscular | NALOXONE HYDROCHLORIDE 1 MG | Cancelled Post Market | |
| 02453266 | S.O.S. NALOXONE HYDROCHLORIDE INJECTION | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Subcutaneous; Intramuscular | NALOXONE HYDROCHLORIDE 1 MG | Cancelled Pre Market |
Browse other molecules: